We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nissan (NSANY) Aims to Grow Market Share Outside America
Read MoreHide Full Article
Nissan Motor Company (NSANY - Free Report) has reported that it is anticipating vehicle sales growth in a few markets to outperform the industry, per Reuters. This Japanese automaker expects to outshine in Asian and African markets. This is critical for Nissan as it is dealing with adversity in the United States, due to declining sales figure.
In the past few years, the company was focused to increase its market share in the United States, in which it roughly doubled vehicle sales since 2010. However, doubling sales, by offering huge discounts, led to declining operating profits for Nissan. This has prompted the automaker to rethink its strategy and reduce production in North America. (Read more: Nissan to Lower North American Output, Raise Profitability)
Currently, the company is aiming for expansion in China, Africa, Middle East and India to boost growth, as well as to improve profitability in North America. Moreover, Nissan is planning to enter Pakistan and Turkey, in which it has no presence as of now.
For India, one of Nissan’s focus markets, the company is depending on more sport utility vehicles (SUVs) and low-cost Datsun-branded vehicles. The country has been observing rise in sales of SUVs, driven by increasing spending power of consumers.
For South Africa, the company will focus on selling more passenger cars and fewer pick-up trucks. Management anticipates market share to more than 15% in the country by 2022 compared with 10% recorded in 2017. Similarly, in Saudi Arabia, the figure is expected to increase by 14% in 2022 compared with 7% recorded in 2017 end.
Price Performance
In the past six months, Nissan’s stock has moved up 2.7%, outperforming 0.2% increase of the industry it belongs to.
General Motors has an expected long-term growth rate of 5.5%. Shares of the company have risen 28.5% over the past year.
Ferrari has an expected long-term growth rate of 17.3%. Shares of the company have risen 64.5% over the past year.
Peugeot has an expected long-term growth rate of 19.2%. Shares of the company have risen 23% over the past year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Nissan (NSANY) Aims to Grow Market Share Outside America
Nissan Motor Company (NSANY - Free Report) has reported that it is anticipating vehicle sales growth in a few markets to outperform the industry, per Reuters. This Japanese automaker expects to outshine in Asian and African markets. This is critical for Nissan as it is dealing with adversity in the United States, due to declining sales figure.
In the past few years, the company was focused to increase its market share in the United States, in which it roughly doubled vehicle sales since 2010. However, doubling sales, by offering huge discounts, led to declining operating profits for Nissan. This has prompted the automaker to rethink its strategy and reduce production in North America. (Read more: Nissan to Lower North American Output, Raise Profitability)
Currently, the company is aiming for expansion in China, Africa, Middle East and India to boost growth, as well as to improve profitability in North America. Moreover, Nissan is planning to enter Pakistan and Turkey, in which it has no presence as of now.
Nissan Motor Co. Price and Consensus
Nissan Motor Co. Price and Consensus | Nissan Motor Co. Quote
For India, one of Nissan’s focus markets, the company is depending on more sport utility vehicles (SUVs) and low-cost Datsun-branded vehicles. The country has been observing rise in sales of SUVs, driven by increasing spending power of consumers.
For South Africa, the company will focus on selling more passenger cars and fewer pick-up trucks. Management anticipates market share to more than 15% in the country by 2022 compared with 10% recorded in 2017. Similarly, in Saudi Arabia, the figure is expected to increase by 14% in 2022 compared with 7% recorded in 2017 end.
Price Performance
In the past six months, Nissan’s stock has moved up 2.7%, outperforming 0.2% increase of the industry it belongs to.
Zacks Rank & Stocks to Consider
Currently, Nissan has a Zacks Rank #3 (Hold). A few better-ranked stocks in the auto space are General Motors Company (GM - Free Report) , Ferrari N.V. (RACE - Free Report) and Peugeot S.A. , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
General Motors has an expected long-term growth rate of 5.5%. Shares of the company have risen 28.5% over the past year.
Ferrari has an expected long-term growth rate of 17.3%. Shares of the company have risen 64.5% over the past year.
Peugeot has an expected long-term growth rate of 19.2%. Shares of the company have risen 23% over the past year.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>